Search | Page 14 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Clinical Trials Report for April 2014

    ... identifier: NCT01900119 Post Transplant Cyclophosphamide Cytoxan) for GvHD Prophylaxis The main purpose of this study is to assess the effects of cyclophosphamide (cytoxan) in the post transplant setting to prevent onset of ...

    Page last updated 04/18/2014 - 3:36pm.

  2. Clinical Trials Report for June 2015

    ... GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a ... and benefit of giving a type of chemotherapy - cyclophosphamide - after the transplant to prevent graft versus host disease ...

    Page last updated 06/18/2015 - 11:47am.

  3. Clinical Trials Report for July 2015

    ... GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a ... and benefit of giving a type of chemotherapy - cyclophosphamide - after the transplant to prevent graft versus host disease ...

    Page last updated 06/24/2015 - 1:43pm.

  4. Clinical Trials Report for May 2015

    ... GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a ... and benefit of giving a type of chemotherapy - cyclophosphamide - after the transplant to prevent graft versus host disease ...

    Page last updated 04/28/2015 - 11:38am.

  5. Research Retrospective for AA&MDSIF 30th Anniversary - Dr. Neal Young

    ... is more intensive immuosuppresion using rabbit ATG or cyclophosphamide . I think those have yielded disappointing results. It is ...

    Interview last updated 05/08/2013 - 2:51pm.

  6. Transplantation Update

    ... is it possible to reduce or even completely avoid cyclophosphamide (Cytoxan®) by instead using fludarabine , ... showed that this can work, but we can’t completely omit cyclophosphamide because there was failure of engraftment when this ...

    Interview last updated 05/14/2015 - 2:42pm.

  7. North American Pediatric Aplastic Anemia Consortium Symposium

    ... sibling transplant in SAA with a conditioning regimen of Cyclophosphamide and ATG at 3 years is 90%. The typical time to transplant ...

    Page last updated 10/31/2013 - 4:06pm.

  8. Interviews with the Experts Transplantation & GVHD: What Patients Need to Know

    ... dose regimen might consist of busulfan combined with cyclophosphamide (Cytoxan®), while a low intensity regimen might consist ...

    Interview last updated 09/30/2014 - 11:07am.

  9. Transplantation Basics

    ... dose regimen might consist of busulfan combined with cyclophosphamide (Cytoxan®), while a low intensity regimen might consist ...

    Interview last updated 04/05/2013 - 2:33pm.

  10. Issues for Parents of Pediatric Bone Marrow Failure Patients

    ... that have been utilized. Johns Hopkins has utilized cyclophosphamide , also known as Cytoxan, as an immune suppressant, so those ...

    Page last updated 06/20/2011 - 12:10pm.